+987.9%
MRNA vs FCUV
-98.1%
+1,086.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FCUV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -7.5% | +20.6% | +13.0% |
| 7D | +20.6% | -8.6% | +29.2% | +20.6% |
| 30D | +27.1% | -25.9% | +53.1% | +26.9% |
| 3M | +353.4% | -69.8% | +423.2% | +352.3% |
| 6M | +446.3% | -31.6% | +477.9% | +471.3% |
| YTD | +776.2% | -90.1% | +866.3% | +853.5% |
| 1Y | +987.9% | -98.0% | +1,085.9% | +1,117.8% |
| All | +987.9% | -98.1% | +1,086.0% | +1,117.8% |
Cumulative growth
Daily Returns
Daily percentage return beside FCUV.
Daily Out/Under-Performance
Portfolio return minus FCUV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FCUV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FCUV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling